{"id":"274093330410-67","name":"Knowledge Ecology International Europe","registrationDate":"2018-02-27T00:31:05.843+01:00","category":3,"subCategory":2,"legal":"Association","web":"http://keieurope.org","country":"Switzerland","headAddress":"Route de Morillons 1","headCity":"Geneva","headPostCode":"1211","headPhone":"(41)2 27 91 67 27","boss":"Elisabeth â€™t Hoen","bossTitle":"Ms","bossPosition":"President","membersCount":1,"membersFTE":"0.5","membership":"Trans Atlantic Consumer Dialogue - http://tacd.org/","memberOrga":"Knowledge Ecology International Europe (KEI Europe) is a non-profit organization focusing on the management of knowledge, including innovation and access to knowledge goods.&#xd;\n&#xd;\nKEI Europe is a not-for-profit Swiss association with offices in Geneva, Switzerland. &#xd;\n&#xd;\nThere are four natural persons who are members of KEI Europe. http://keieurope.org/about.html","goal":"Knowledge Ecology International Europe (KEI Europe) is a non-profit organization focusing on the management of knowledge, including innovation and access to knowledge goods.&#xd;<br />&#xd;<br />KEI Europe is a not-for-profit Swiss association with offices in Geneva, Switzerland.&#xd;<br />&#xd;<br />KEI Europe monitors Brussels and Geneva-based trade, health and IPR negotiations, KEI Europe has extensive contacts within governments, academics, consumers organizations and other stakeholders.&#xd;<br />&#xd;<br />As part of its work, KEI Europe endeavors to ensure policy coherence across between positions adopted by the European Union in Brussels with their engagement with global institutions, such as the WHO, WIPO and WTO","acronym":"KEI Europe","interests":"Business and Industry, Climate Action, Competition, Consumers, Culture, Culture and media, Digital economy and society, Education and training, International co-operation and development, Public Health, Research and innovation, Single market, Trade","euInitiatives":"http://keieurope.org/actions.html&#xd;<br />&#xd;<br />In recent years, KEI Europe has advanced a positive agenda in the Transatlantic Trade and Investment (TTIP) negotiations, submitted a detailed proposal to the Government of the United Kingdom requesting the government to issue a compulsory licence on the costly breast cancer treatment, T-DM1, and  engaged in media advocacy with the Franco-German television network, ARTE, on the subject of donor capture of the World Health Organization (WHO). &#xd;<br />&#xd;<br />Some highlights include:&#xd;<br />&#xd;<br />Horizon 2020&#xd;<br />&#xd;<br />2 February 2017. KEI Europe, along with a coalition of groups, called upon the European Commission to reframe Horizon 2020 to explore alternative models of innovation that delinked the cost of R&amp;D from the price of medicines.&#xd;<br />&#xd;<br />January 2017. The joint submission to the Horizon 2020 consultation established six key recommendations that the European Commission should consider during their review process, including increased public investment in biomedical R&amp;D funding, mandates on open data, and increased transparency.&#xd;<br />&#xd;<br />Transatlantic Trade and Investment Partnership Agreement&#xd;<br />&#xd;<br />24 February 2016. KEI Europe delivered an intervention before EU and US TTIP negotiators as well as stakeholders during the 12th round of negotiations in Brussels.&#xd;<br />&#xd;<br />15 July 2015. KEI Europe presented an intervention on issues related to intellectual property and public health at the TTIP stakeholder event during the negotiations in Brussels.&#xd;<br />&#xd;<br />13 July 2014. KEI Europe Submission: European Commission's Public consultation on modalities for investment protection and ISDS in TTIP.","lastUp":"2019-02-18T11:50:55.730+01:00","customers":"","costAbsolu":"","costRange":"25000-49999","turnoverAbsolu":0,"turnoverRange":""}